Our previous in vitro studies in rat hippocampal neurons in primary culture demonstrated that either shRNA-mediated knockdown of endogenous MeCP2 protein levels or overexpression of human MECP2 missense mutations common in RTT patients (R106W or T158M) reduced dendritic length and branching during early neuronal development [29]. The gene discussed is MECP2; the disease is Rett syndrome.